PharmaShots Weekly Snapshots (Feb 08 – 12, 2021)

Visby’s POC COVID-19 Test Receives the US FDA’s EUA for Use in CLIA Waived Settings

Published: Feb 12, 2020 | Tags: Visby, POC, COVID-19, Test, Receives, US, FDA, EUA, Use, CLIA, Waived, Settings

Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies

Published: Feb 12, 2020 | Tags: Takeda, Collaborates, Ensoma, Accelerate, Next-Generation, Vivo Gene Therapies

Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

Published: Feb 12, 2020 | Tags: Roche, Reports, Results, Faricimab, Four, P-III, Studies, Diabetic, Macular Edema, Age-Related Macular Degeneration

Regeneron’s Evkeeza (evinacumab-dgnb) Receives the US FDA’s Approval for Patients with Homozygous Familial Hypercholesterolemia

Published: Feb 12, 2020 | Tags: Regeneron, Evkeeza (evinacumab-dgnb), Receives, US, FDA, Approval, Patients, Homozygous Familial Hypercholesterolemia

Novartis to Acquire GSK’s Cephalosporin Antibiotics Business

Published: Feb 12, 2020 | Tags: Novartis, Acquire, GSK, Cephalosporin, Antibiotics, Business

BMS Collaborates with Molecular Templates to Develop Engineered Toxin Body Therapies for Cancer

Published: Feb 12, 2020 | Tags: BMS, Collaborates, Molecular Templates, Develop, Engineered, Toxin, Body, Therapies, Cancer

Evotec Collaborates with Related Sciences for Drug Discovery and Development

Published: Feb 11, 2020 | Tags: Evotec, Collaborates, Related Sciences, Drug Discovery, Development

AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU

Published: Feb 11, 2020 | Tags: AstraZeneca, Signs, Letter, Intent, IDT Biologika, Boost, COVID-19 Vaccine, Manufacturing, Capability, EU

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

Published: Feb 11, 2020 | Tags: Sanofi, Collaborates, i2O Therapeutics, Evaluate, Oral, i2O Therapeutics

AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies Published: Feb 11, 2020 | Tags: AbbVie, Signs, License Agreement, Caribou Biosciences, CAR-T Cell Therapies

Galapagos and Gilead Discontinue the P-III Trials of Ziritaxestat (GLPG1690) for Idiopathic Pulmonary Fibrosis

Published: Feb 11, 2020 | Tags: Galapagos, Gilead, Discontinue, P-III, Trials, Ziritaxestat (GLPG1690), Idiopathic Pulmonary Fibrosis

Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners

Published: Feb 11, 2020 | Tags: Kaia Health, Offers, Complete, Musculoskeletal Care Solution, Kaia Gateway, Premium Partners

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Published: Feb 10, 2020 | Tags: Lonza, Divest, Specialty, Ingredients, Business, Bain Capital, Cinven ,$4.7B

Vico’s VO659 Receives EC’s Orphan Drug Designation for Spinocerebellar Ataxia

Published: Feb 10, 2020 | Tags: Vico, VO659, Receives, EC, Orphan Drug Designation,  Spinocerebellar Ataxia

Lannett Expand its Partnership with HEC to Include Biosimilar Fast-Acting Insulin

Published: Feb 10, 2020 | Tags: Lannett, Expand, Partnership, HEC, Include, Biosimilar, Fast-Acting, Insulin

Eli Lilly and AbCellera’s Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Receive the US FDA’s EUA for COVID-19

Published: Feb 10, 2020 | Tags: Eli Lilly, AbCellera, Bamlanivimab (LY-CoV555), Etesevimab (LY-CoV016), Receive, US, FDA, EUA, COVID-19

Regeneron and Sanofi’s Libtayo (cemiplimab-rwlc) Receives US FDA’s Approval for Patients with Advanced Basal Cell Carcinoma

Published: Feb 10, 2020 | Tags: Regeneron, Sanofi, Libtayo (cemiplimab-rwlc), Receives, US, FDA, Approval,  Patients, Advanced Basal Cell Carcinoma

Lee’s Pharma Socazolimab Receives NMPA’s Breakthrough Therapy Designation for Treatment of Recurrent or Metastatic Cervical Cancer

Published: Feb 10, 2020 | Tags: Lee’s Pharma, Socazolimab, Receives, NMPA, Breakthrough Therapy Designation, Treatment, Recurrent, Metastatic, Cervical Cancer
BMS Report Results of Opdivo (nivolumab) + Cabometyx (cabozantinib) in P-III CheckMate -9ER Trial for 1L Treatment of Advanced Renal Cell Carcinoma

Published: Feb 9, 2020 | Tags: BMS, Report, Results, Opdivo (nivolumab), Cabometyx (cabozantinib), P-III, CheckMate -9ER Trial, 1L, Treatment, Advanced Renal Cell Carcinoma

Medidata Launches Sensor Cloud to Connect Device and Wearables in Clinical Trials

Published: Feb 9, 2020 | Tags: Medidata, Launches, Sensor Cloud, Connect, Device, Wearables,  Clinical Trials

BMS’ Inrebic (fedratinib) Receives EC’s Approval for Patients with Newly Diagnosed and Previously Treated Myelofibrosis

Published: Feb 9, 2020 | Tags: BMS, Inrebic (fedratinib), Receives, EC, Approval, Patients, Newly Diagnosed, Previously, Treated, Myelofibrosis

Signifier’s eXciteOSA Receives US FDA’s Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring

Published: Feb 9, 2020 | Tags: Signifie, eXciteOSA, Receives, US, FDA, Approval, Treatment, Mild Obstructive, Sleep Apnea, Snoring

Hologic Collaborate with Google Cloud to Advance Screening in Cervical Cancer

Published: Feb 9, 2020 | Tags: Hologic, Collaborate, Google Cloud, Advance, Screening, Cervical Cancer

ViiV Healthcare’s Rukobia (fostemsavir) Receives Marketing Authorization for the Treatment of Adults with Multidrug-Resistant HIV

Published: Feb 9, 2020 | Tags: ViiV Healthcare, Rukobia (fostemsavir), Receives, Marketing Authorization, Treatment, Adults, Multidrug-Resistant HIV

Celltrion’s Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19

Published: Feb 8, 2020 | Tags: Celltrion, Regdanvimab (CT-P59), Receives, Korean, MFDS, Conditional Marketing Authorization, COVID-19

AstraZeneca’s Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study

Published: Feb 8, 2020 | Tags: AstraZeneca, Imfinzi, Fails, Meet, Primary Endpoints, P-III, KESTREL ,Study

CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants

Published: Feb 8, 2020 | Tags: CureVac, Collaborate, UK, Government, Develop, Vaccines, Against, SARS-CoV-2 variants

Roche’s Elecsys GDF-15 Assay Receives the US FDA’s Breakthrough Device Designation as a CDX in Cancer Treatment

Published: Feb 8, 2020 | Tags: Roche, Elecsys, GDF-15, Assay, Receives, US, FDA, Breakthrough Device Designation, CDX, Cancer, Treatment

Daiichi Sankyo Signs an Outsourcing Agreement with AstraZeneca for COVID-19 Vaccine in Japan

Published: Feb 8, 2020 | Tags: Daiichi Sankyo, Signs, Outsourcing Agreement, AstraZeneca, COVID-19, Vaccine, Japan

BMS’ Breyanzi (lisocabtagene maraleucel) Receives the US FDA’s Approval for Adults With R/R Large-B-Cell Lymphoma

Published: Feb 8, 2020 | Tags: BMS, Breyanzi (lisocabtagene maraleucel), Receives, US, FDA, Approval, Adults, R/R Large-B-Cell Lymphoma

Related post: PharmaShots Weekly Snapshot (Feb 01-05, 2021)